Formosa Laboratories, Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Formosa Laboratories, Inc with three other
companies in this sector in TAIWAN :
Tty Biopharm Company Limited
sales of 4.22 billion Taiwanese Dollars [US$152.62 million]
of which 58%
was Anti-Cancer Drug),
Synmosa Biopharma Corp
(3.04 billion Taiwanese Dollars [US$109.83 million]
of which 96%
was Generic Drugs), and
Sinphar Pharmaceutical C O., Ltd.
(2.39 billion Taiwanese Dollars [US$86.34 million]
of which 66%
During the first
quarter of 2021, sales at Formosa Laboratories, Inc totalled
736.28 million Taiwanese Dollars .
an increase of 11.1%
from the 662.64 million Taiwanese Dollars in sales at the company during the first quarter of 2020.
During the previous 7 quarters, sales at Formosa Laboratories, Inc have increased compared with the same quarter in the previous year.
Formosa Laboratories, Inc reported sales of 3.08 billion Taiwanese Dollars (US$111.18 million)
December of 2020.
increase of 11.4%
versus 2019, when the company's sales were 2.76 billion Taiwanese Dollars .
This was the third consecutive year of growth at Formosa Laboratories, Inc.